CNBX Pharmaceuticals Inc. (CNBX) Change in Account Payables (2011 - 2015)

CNBX Pharmaceuticals (CNBX) has 5 years of Change in Account Payables data on file, last reported at $39999.0 in Q3 2015.

• Quarterly Change in Account Payables fell 18.03% year-over-year to $39999.0 in Q3 2015, while the trailing twelve-month figure through May 2016 was $39999.0 (down 78.32% YoY) and the FY2018 annual result came in at -$249.0, changed N/A from the prior year.
• Change in Account Payables declined to $39999.0 in Q3 2015, from $99001.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $99001.0 in Q2 2015 to a low of -$40000.0 in Q2 2014.
• A 5-year average of $16185.0 and a median of $6683.0 in 2014 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2014 — Change in Account Payables surged 1526.67% — and 2015, when it slipped 18.03%.
• Tracing CNBX's Change in Account Payables over 5 years: stood at -$22190.0 in 2011, then surged by 115.95% to $3540.0 in 2012, then slumped by 224.12% to -$4394.0 in 2013, then jumped by 252.09% to $6683.0 in 2014, then jumped by 498.52% to $39999.0 in 2015.
• The last three Change in Account Payables figures came in at $39999.0 (Q3 2015), $99001.0 (Q2 2015), and $30000.0 (Q1 2015), per Business Quant data.